Clinical Trial Update: Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carrelizumab (PD-1) with chemotherapy as neoadjuvant treatment for locally advanced gastric cancer; status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Carrelizumab (camrelizumab)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Locally Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN